BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2451486)

  • 1. Use-dependent blockade of sodium channels induced by bencyclane in frog skeletal muscle and canine cardiac Purkinje fiber.
    Nánási PP; Varró A; Rablóczky G; Dankó M
    Arch Int Pharmacodyn Ther; 1987 Dec; 290(2):278-87. PubMed ID: 2451486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bencyclane on normal and cevadine-modified Na channels in frog skeletal muscle.
    Nánási PP; Bodnár Z; Dankó M
    Gen Physiol Biophys; 1989 Oct; 8(5):447-58. PubMed ID: 2556322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency-dependent interactions of mexiletine and quinidine on depolarization and repolarization in canine Purkinje fibers.
    Roden DM; Iansmith DH; Woosley RL
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1218-24. PubMed ID: 2447269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voltage- and rate-dependent depression of Vmax of action potentials by a new antiarrhythmic agent, E-0747, in swine cardiac Purkinje fibers.
    Sawada K; Shoji T; Igarashi T; Hiraoka M
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):51-6. PubMed ID: 2434794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and voltage-dependent effects of mono-N-dealkyldisopyramide, the major metabolite of disopyramide, in canine ventricular tissue.
    Toy W; Sasyniuk BI
    J Pharmacol Exp Ther; 1990 Aug; 254(2):603-11. PubMed ID: 2166798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological effects of ACC-9358, a novel class I antiarrhythmic agent, on isolated canine Purkinje fibers and ventricular muscle.
    Brown BS
    J Pharmacol Exp Ther; 1989 Feb; 248(2):552-8. PubMed ID: 2918472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of quinidine on the transmembrane potentials of young and adult canine cardiac Purkinje fibers.
    Morikawa Y; Rosen MR
    J Pharmacol Exp Ther; 1986 Mar; 236(3):832-7. PubMed ID: 3950873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine and prostacyclin independent electrophysiological effects of dipyridamole in guinea-pig papillary muscles and canine cardiac Purkinje fibers.
    Rardon DP; Kovacs RJ; Bailey JC
    J Pharmacol Exp Ther; 1984 Oct; 231(1):206-13. PubMed ID: 6092602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cryptand 2.2.1Py on the fast sodium current in cardiac Purkinje fibers.
    Achenbach C; Hauswirth O; Kossmann J; Ziskoven R
    Physiol Chem Phys; 1980; 12(3):277-88. PubMed ID: 6254103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers.
    Nattel S
    J Pharmacol Exp Ther; 1987 Apr; 241(1):282-8. PubMed ID: 3572790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of adriamycin on normal and ouabain-toxic canine Purkinje and ventricular muscle fibers.
    Binah O; Cohen IS; Rosen MR
    Circ Res; 1983 Nov; 53(5):655-62. PubMed ID: 6313254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery from use-dependent block of Vmax and restitution of action potential duration in canine cardiac Purkinje fibers.
    Elharrar V
    J Pharmacol Exp Ther; 1988 Jul; 246(1):235-42. PubMed ID: 3392655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ouabain-induced changes in electrophysiologic properties of neonatal, young and adult canine cardiac Purkinje Fibers.
    Rosen MR; Hordof AJ; Hodess AB; Verosky M; Vulliemoz Y
    J Pharmacol Exp Ther; 1975 Jul; 194(1):255-63. PubMed ID: 1151753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency-dependent effects of antiarrhythmic drugs on action potential duration and refractoriness of canine cardiac Purkinje fibers.
    Nattel S; Zeng FD
    J Pharmacol Exp Ther; 1984 Apr; 229(1):283-91. PubMed ID: 6707943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lidocaine and on slow response and depressed fast response action potentials of canine cardiac Purkinje fibers.
    Brennan FJ; Cranefield PF; Wit AL
    J Pharmacol Exp Ther; 1978 Feb; 204(2):312-24. PubMed ID: 621666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of the frequency- and voltage-dependent effects of quinidine when administered in combination with tocainide in canine Purkinje fibers.
    Valois M; Sasyniuk BI
    Circulation; 1987 Aug; 76(2):427-41. PubMed ID: 2440617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use-dependent action of antiarrhythmic drugs in frog skeletal muscle and canine cardiac Purkinje fiber.
    Nánási PP; Varró A; Lathrop DA; Dankó M
    Gen Pharmacol; 1990; 21(5):747-51. PubMed ID: 2276592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological effects of carocainide (770207) on canine ventricular muscle and Purkinje fibers.
    Pourrias B; Santamaria R
    Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):85-95. PubMed ID: 6316863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the electrophysiologic effects of acute and chronic amiodarone administration on canine Purkinje fibers.
    Gallagher JD; Bianchi J; Gessman LJ
    J Cardiovasc Pharmacol; 1989 May; 13(5):723-9. PubMed ID: 2472520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological actions of mexiletine (Kö1173) on canine Purkinje fibres and ventricular muscle.
    Arita M; Goto M; Nagamoto Y; Saikawa T
    Br J Pharmacol; 1979 Sep; 67(1):143-52. PubMed ID: 497518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.